ConductScience.org, home

Paper23219031

Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI).

Bialer M and 5 others. Epilepsy Res, 2013. Cited by 196 papers, by iCite.

Cite this record

ConductScience Library. Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Papers, record 23219031. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23219031

Download JSON
Disease
Focal-onset seizure27 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI).
PubMed
Journal
Epilepsy Res
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
196
iCite
Relative citation ratio, by iCite
6.72
iCite
Revised in PubMed
2013-01-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bialer MMeir
2Johannessen SISvein I
3Levy RHRené H
4Perucca EEmilio
5Tomson TTorbjörn
6White HSH Steve

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticonvulsantsMajor topic
Congresses as TopicMajor topic
Drugs, InvestigationalMajor topic
EpilepsyMajor topic
Research ReportMajor topic
Animals
Clinical Trials as Topic
Humans
Israel

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01397968Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset SeizuresDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.

PMIDTitleJournalYearIn PapersSource
42977736Epilepsy: epidemiology, risk factors, classification, pathophysiology, clinical features, diagnosis and management.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42977736PubMed
42246053The cumulative impact of seizures: the science underlying how seizures beget seizures.Front Neurol2026https://conductscience.org/library/papers/42246053PubMed
42111266Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies.Front Cell Dev Biol2026https://conductscience.org/library/papers/42111266PubMed
41951906The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant Epilepsy.CNS Drugs2026https://conductscience.org/library/papers/41951906PubMed
41915362The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and Padsevonil.CNS Drugs2026https://conductscience.org/library/papers/41915362PubMed
41764707Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.Drugs2026https://conductscience.org/library/papers/41764707PubMed
41322155Dual-functional pH-sensitive nanoliposomes modified with CD47 mimicry peptide enhance icariin delivery to attenuate neuroinflammation and oxidative stress in epilepsy.Mater Today Bio2025https://conductscience.org/library/papers/41322155PubMed
41155637IL-1β and HMGB1 in Epileptogenesis: Recent Advances and Clinical Translation.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155637PubMed
41059206Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study.Front Pharmacol2025https://conductscience.org/library/papers/41059206PubMed
40526193Pyroptosis in Alzheimer's Disease: Mechanisms and Therapeutic Potential.Cell Mol Neurobiol2025https://conductscience.org/library/papers/40526193PubMed
40384045Cenobamate in Real-Word Scenario: Results on Efficacy, Side Effects, and Retention Rate in a Single Center Retrospective Study.Brain Behav2025https://conductscience.org/library/papers/40384045PubMed
39853501Targeting Kv7 Potassium Channels for Epilepsy.CNS Drugs2025https://conductscience.org/library/papers/39853501PubMed
39684724Cenobamate, a New Promising Antiseizure Medication: Experimental and Clinical Aspects.Int J Mol Sci2024https://conductscience.org/library/papers/39684724PubMed
39251813Inflammasome components as new therapeutic targets in inflammatory disease.Nat Rev Immunol2025https://conductscience.org/library/papers/39251813PubMed
38791515
Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 Assembly.
Int J Mol Sci2024https://conductscience.org/library/papers/38791515PubMed
38740765Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics.Cell Death Discov2024https://conductscience.org/library/papers/38740765PubMed
38675544New Findings on the Crystal Polymorphism of Imepitoin.Molecules2024https://conductscience.org/library/papers/38675544PubMed
38489314Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.PLoS One2024https://conductscience.org/library/papers/38489314PubMed
38449838Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials.EClinicalMedicine2024https://conductscience.org/library/papers/38449838PubMed
37893198The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models.Biomedicines2023https://conductscience.org/library/papers/37893198PubMed

See all 113 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
CENOBAMATECHEMBL3989949Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3989949

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23219031

GET https://conductscience.org/api/papers/v1/23219031/cited_by?page=2